Douglas S. Compton

Diet-induced obese mice develop peripheral, but not central, resistance to leptin.

Margaret van Heek, Douglas S. Compton, C F France et al. · Journal of Clinical Investigation · 1997 · 750 citations · Full text

Medicine, Endocrinology, Nutritional Sciences +13

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

Margaret van Heek, Constance Farley, Douglas S. Compton et al. · British Journal of Pharmacology · 2000 · 327 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461

Margaret van Heek, Constance F. France, Douglas S. Compton et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 305 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Inhibits the Development of Atherosclerosis in ApoE Knockout Mice

Harry R. Davis, Douglas S. Compton, Lizbeth Hoos et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2001 · 218 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function

Margaret van Heek, Constance Farley, Douglas S. Compton et al. · British Journal of Pharmacology · 2001 · 216 citations · Full text

Medicine, Biochemistry, Pharmacology +17